In the latest market close, Recursion Pharmaceuticals (RXRX) reached $6.67, with a -0.74% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.76%.
Morgan Stanley’s wealth-management unit broke a four-quarter streak of year-over-year declines. Net new assets surged 79% from a year ago to $63.9 billion. That is the first increase since the second ...
Futures are pointing to a slightly higher open for major indexes on Wednesday as the stock market looks to recover from sharp ...